Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Rexahn Pharmaceuticals Inc (NYSE MKT LLC:RNN)

0.2226
Delayed Data
As of 3:59pm ET
 +0.0042 / +1.92%
Today’s Change
0.20
Today|||52-Week Range
0.64
-38.68%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization42.4K37.1K28.3K27.5K
 
 
 
 
 
 
Operating ExpensesGross Income-42.4K-37.1K-28.3K-27.5K
 
 
 
 
 
General Expenses6.1M7.9M13.2M18.2M
 
 
 
 
 
Other Operating Expenses431.1K0.000.000.00
 
 
Research And Development3.4M3.3M7.0M12.1M
 
 
 
 
 
Total Operating Expenses6.6M8.0M13.3M18.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-6.6M-8.0M-13.3M-18.3M
 
 
 
 
 
Extraordinary Credit663.9K0.000.004.0M
 
 
 
Extraordinary Charge-332.1K-1.4M-5.2M0.00
 
 
 
 
Other Expenses0.00-204.2K-206.2K-211.1K
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-6.2M-9.5M-18.5M-14.4M
 
 
 
 
 
Net Income-6.2M-9.5M-18.5M-14.4M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS97.1M128.6M176.1M182.4M
 
 
 
 
 
Shares To Calculate EPS Diluted97.1M128.6M176.1M182.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.06-$0.07-$0.11-$0.08
 
 
 
 
 
EPS Diluted-$0.06-$0.07-$0.11-$0.08